Comparison between antineoplastic treatments with selective inhibitors (BRAF/MEK) and the new potentials combinatorial therapies for metastatic melanoma. Research, Society and Development, [S. l.], v. 11, n. 14, p. e326111436275, 2022. DOI: 10.33448/rsd-v11i14.36275. Disponível em: https://rsdjournal.org/rsd/article/view/36275. Acesso em: 5 dec. 2025.